GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Health Guard Biotechnology Inc (BJSE:833575) » Definitions » Debt-to-Asset

Beijing Health Guard Biotechnology (BJSE:833575) Debt-to-Asset : 0.14 (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Beijing Health Guard Biotechnology Debt-to-Asset?

Beijing Health Guard Biotechnology's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was ¥144.83 Mil. Beijing Health Guard Biotechnology's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was ¥62.38 Mil. Beijing Health Guard Biotechnology's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2024 was ¥1,508.35 Mil. Beijing Health Guard Biotechnology's debt to asset for the quarter that ended in Jun. 2024 was 0.14.


Beijing Health Guard Biotechnology Debt-to-Asset Historical Data

The historical data trend for Beijing Health Guard Biotechnology's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Health Guard Biotechnology Debt-to-Asset Chart

Beijing Health Guard Biotechnology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.02 0.02 0.16 0.05

Beijing Health Guard Biotechnology Quarterly Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.07 0.05 0.11 0.14

Competitive Comparison of Beijing Health Guard Biotechnology's Debt-to-Asset

For the Biotechnology subindustry, Beijing Health Guard Biotechnology's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Health Guard Biotechnology's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Health Guard Biotechnology's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Beijing Health Guard Biotechnology's Debt-to-Asset falls into.



Beijing Health Guard Biotechnology Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Beijing Health Guard Biotechnology's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(30.347 + 36.547) / 1454.292
=0.05

Beijing Health Guard Biotechnology's Debt-to-Asset for the quarter that ended in Jun. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(144.829 + 62.378) / 1508.353
=0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Health Guard Biotechnology  (BJSE:833575) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Beijing Health Guard Biotechnology Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Beijing Health Guard Biotechnology's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Health Guard Biotechnology Business Description

Traded in Other Exchanges
N/A
Address
No. 7 Rongchang East Street, Beijing Economic and Technological Development Zone, Room 201 and 202, Building A2, Beijing, CHN, 100176
Website
Beijing Health Guard Biotechnology Inc engages in the research, development, and industrialization of recombinant protein vaccines. It mainly develops HPV vaccines in China and also advances multiple innovative candidate vaccines for other infectious diseases. Its core pipeline product includes a trivalent and a nonavalent HPV vaccine.

Beijing Health Guard Biotechnology Headlines

No Headlines